CELL2B

cell2b-logo

Cell2B is a biotechnology company that develops advanced cellular therapies for its patients. Its aim is to deliver a set of therapies to patients and caregivers to tackle immune, inflammatory, and oncological malignancies. Cell2B develops new proprietary techniques and protocols to increase their numbers and effectiveness in tissue and organ regeneration. Founded in 2011, it is headquartered in Cantanhede, Coimbra.

#SimilarOrganizations #Financial #Website #More

CELL2B

Social Links:

Industry:
Biotechnology Health Care

Founded:
2011-01-01

Address:
Cantanhede, Coimbra, Portugal

Country:
Portugal

Website Url:
http://www.cell2b.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
0

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Wordpress Plugins Global Site Tag


Similar Organizations

affini-t-therapeutics-logo

Affini-T Therapeutics

Affini-T Therapeutics is a biotechnology company developing T-cell therapies for patients suffering from cancer.

beren-therapeutics-logo

Beren Therapeutics

Beren Therapeutics is a biotechnology company that develops innovative therapies to make them accessible to every patient.

edvince-logo

Edvince

Edvince is a biotechnology company that develops a new treatment.

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

Investors List

changepartners_image

ChangePartners

ChangePartners investment in Venture Round - Cell2B

Official Site Inspections

http://www.cell2b.com

Unable to get host informations!!!

Loading ...

More informations about "Cell2B"

Cell2B - Crunchbase Company Profile & Funding

Cell2B is a biotechnology company that develops advanced cellular therapies for its patients. Its aim is to deliver a set of therapies to patients and caregivers to tackle immune, inflammatory, โ€ฆSee details»

Cell2B - Funding, Financials, Valuation & Investors - Crunchbase

Nov 19, 2013 Cell2B is a biotechnology company that develops advanced cellular therapies for its patients. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. ...See details»

Cell2B Company Profile | Management and Employees List

Cell2B is a biotechnology company dedicated to the development of advanced cellular therapies. Our goal is to deliver a new set of therapies to patients and caregivers to tackle immune, โ€ฆSee details»

Cell2B Company Profile 2024: Valuation, Funding & Investors

Cell2B General Information Description. Developer of a cell therapy intended to prevent and treat organ rejection. The company's therapy targets acute Graft-versus-Host-Disease (GvHD), a โ€ฆSee details»

Cell2B Information - RocketReach

Cell2B is a biotechnology company dedicated to the development of a new line of healthcare therapies to prevent and treat organ rejection in patients undergoing organ or tissue โ€ฆSee details»

Interview: David Malta and Daniela Couto, Co-Founders, Cell2B, โ€ฆ

Jul 30, 2014 What makes Cell2B the partner of choice among all the cell-based therapy companies in Portugal? DM: Cell2B is the most developed company, and the only one ready โ€ฆSee details»

Cell2B - VentureRadar

Similar Companies: InnDura Therapeutics USA n/a InnDura Therapeutics is developing breakthrough NK cell therapies that change lives. InnDura's platform is based on licensed โ€ฆSee details»

Biotech of the week: Cell2b, Promising Portugese Cell Therapy

Oct 2, 2015 ImmuneSafe works by modulating the immune and inflammatory responses and promoting tissue regeneration. Cell2B hope it will able to treat other immunological and โ€ฆSee details»

Cell2B - Advanced Therapeutics SA - Drug pipelines, Patents, โ€ฆ

Explore Cell2B - Advanced Therapeutics SA with its drug pipeline, therapeutic area, technology platform, .See details»

Cell2B - Crunchbase

Cell2B is a biotechnology company that develops advanced cellular therapies for its patients.See details»

Cell2B - Overview, News & Similar companies | ZoomInfo.com

Cell2B is a biotechnology company dedicated to the development of advanced cellular therapies. Our goal is to deliver a new set of therapies to pat ients and caregivers to tackle immune, โ€ฆSee details»

โ˜‘๏ธCell2B - Advanced Therapeutics โ€” Consulting Organization โ€ฆ

Oct 11, 2024 Cell2B - Advanced Therapeutics โ€” Consulting Organization from Portugal, has experience with Horizon 2020 (2014 - 2020), it`s involved in Laboratory & Measurement, โ€ฆSee details»

Cell2B - Advanced Therapeutics - F6S

Cell2B is a developer of cell therapies for immune and inflammatory diseases. It was incorporated in 2011 with technology developed by its founders and licensed from the MIT in Boston and โ€ฆSee details»

Orphanet: Cell2B Advanced Therapeutics SA

Cell2B Advanced Therapeutics SA. Biocant Park Parque, Tecnológico de Cantanhede, Nucleo 4, Lote 4A. 3060 197 CANTANHEDE . PORTUGAL. Phone 1: 351 211 211 157 Contact email: โ€ฆSee details»

Cell2B, pushing boundaries in cell therapy - Portugal Startups

Nov 25, 2014 Cell2B, a biotechnology company, has one goal: to deliver a new set of cell therapies to people who tackle immune and inflammatory malignancies. The company with a โ€ฆSee details»

The winner of the Bluepharma/a2b has been announced

The winner was Cell2B, a technology-based company that develops solutions for human organ rejection. The company was founded in 2011 and its goal is to provide a new generation of โ€ฆSee details»

Cell2B - Tech Stack, Apps, Patents & Trademarks - Crunchbase

Cell2B uses 10 technology products and services including HTML5, Google Tag Manager, and jQuery, according to G2 Stack. Cell2B is actively using 5 technologies for its website, โ€ฆSee details»

EU/3/14/1388 - European Medicines Agency

Cell2B Advanced Therapeutics, SA Biocant Park Núcleo 4, Lote 4A 3060-197, Cantanhede Portugal Tel. +351 211 211 157 E-mail: [email protected]. Review of designation. The โ€ฆSee details»

EU/3/13/1129 - orphan designation for treatment of graft-versus โ€ฆ

On 7 June 2013, orphan designation (EU/3/13/1129) was granted by the European Commission to Cell2B Advanced Therapeutics, SA, Portugal, for allogeneic bone-marrow-derived โ€ฆSee details»

Visual & Audible Warning Systems - Cell2

Our focus is on quality, outstanding service and JIT (Just in Time) delivery to customers. In the last decade, Cell2 has expanded internationally and now operates from two locations; Vigo โ€ฆSee details»

linkstock.net © 2022. All rights reserved